Mork Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Mork Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-40,000	Closed	-$473K	–	123
2015 Q4	$473K	Hold	40,000	–	–	0.45%	118
2015 Q3	$467K	Hold	40,000	–	–	0.55%	105
2015 Q2	$577K	Hold	40,000	–	–	0.68%	87
2015 Q1	$558K	Hold	40,000	–	–	0.65%	93
2014 Q4	$552K	Buy	+40,000	New	+$517K	0.42%	127

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Mork Capital Management's LFCR Position: Q1 2016 in Review

Mork Capital Management sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 40,000 shares — an estimated $473K sold.

Mork Capital Management first reported a position in LFCR in Q4 2014 and held it in 5 quarters. The position peaked at $577K in Q2 2015. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

Mork Capital Management reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
Mork Capital Management sold 40,000 Lifecore Biomedical shares in Q1 2016, an estimated $473K.
Mork Capital Management first reported a position in Lifecore Biomedical in Q4 2014 and held it in 5 quarters.
Mork Capital Management's Lifecore Biomedical position peaked at $577K in Q2 2015.
96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on Mork Capital Management's 13F filing for Q1 2016, filed 13 May 2016.